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Background: In recent years, there have been several studies, using a wide variety of methods, aimed at
developing quality indicators for palliative care. In this Quality Indicators for Palliative Care study (Q-PAC study) we
have applied a scientifically rigorous method to develop a comprehensive and valid quality indicator set which can
contribute to a standardized method for use in other countries.
Methods and design: Firstly, an extensive literature review identified existing international quality indicators and
relevant themes for measuring quality in palliative care. Secondly, the most relevant of these were selected by an
expert panel. Thirdly, those prioritized by the experts were scored by a second multidisciplinary expert panel for
usability and relevance, in keeping with the RAND/UCLA-method, combining evidence with consensus among
stakeholders. This panel included carers and policymakers as well as patients and next-of-kin. Fourthly, the draft set
was tested and evaluated in practice for usability and feasibility; the indicators were then translated into
questionnaires presented to patients, next-of-kin and care providers. To encourage the acceptance and use of the
indicators, stakeholders, including national palliative care organizations, were involved throughout the whole
project.
Conclusion: Our indicator development trajectory resulted in a set of quality indicators applicable to all patients in
all palliative care settings. The set includes patient and relative perspectives and includes outcome, process and
structure indicators. Our method can contribute internationally to a more standardized and rigorous approach to
developing quality indicators for palliative care.
Keywords: Quality indicators, Quality measurement, Palliative care, Quality of care, End of life care, Hospice care,
Outcome measures, Developing methodBackground
Quality of care is of interest to everyone receiving or
providing palliative care [1]. Evaluation of quality
informs care providers, administrators and policymakers
about whether patients and their families are receiving
care that fits their needs [2-4]. The challenge for quality
improvement in palliative care is to develop effective* Correspondence: kleemans@vub.ac.be
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reproduction in any medium, provided the orways for the quick and efficient assessment of service
performance and outcomes, as this facilitates the modifi-
cation of services and practices in order to improve the
quality of care at individual and institutional levels [5-8].
For this purpose, quality indicators specifically for pallia-
tive care can be used to address issues unique to this
type of care [9].
Although in the past decade a variety of studies have
focused on quality indicators for palliative care, the
methods found in the literature by which indicators were
developed were not always clearly presented and notal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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different steps of the development process [10-26]. Two
recent systematic efforts have developed a nationwide
quality register system to measure outcomes and quality
of palliative care services: the Palliative Care Outcomes
Collaboration (PCOC)-study in Australia [27], and a
similar registration project in Sweden [28]. While these
projects have resulted in very useful national quality
monitoring systems, they do not strictly make use of
quality indicators but mainly focus on outcome
measures. Additionally they did not seem to aim for a
level of comprehensiveness necessary to evaluate the
various dimensions of palliative care.
It appears that there is a need for a more standardized
method of developing a comprehensive quality indicator
set. Even at a more fundamental level, however, there is also
a need for a common understanding of what quality
indicators are. Quality indicators are well-defined and
measurable aspects of care that give an indication of the
quality of care delivered; they are generally expressed in a
number or percentage, address a specific aspect of care or a
related outcome, and are expressed at an aggregated level,
often the level of care organisations [29-32]. They have to
be clinically relevant, manageable and based on existing evi-
dence, or consensus in the absence of such evidence [30].
Specific properties have to be described: a numerator (ie for
which patients the indicator is positive) and a denominator
(the group of patients being evaluated), a threshold value as
a performance standard and exclusion criteria. Validated
measurement instruments and relevant outcome measures
are preferably used [33]. Confusion persists about outcome
measures, measurement instruments and quality indicators,
with these concepts often used interchangeably and mis-
takenly. Outcome measures are an essential component
of quality, providing a way to evaluate patient- or family-
level status and responses to treatment, measured on an
individual level [34]. However, as quality indicators, they
do not have standardized specifications detailing the
eligible population, data collection procedures and types of
analysis needed to calculate them [24] (see Table 1).
Following the model proposed by Donabedian, quality
indicators should be monitored in all three major areas of
health care: structure, process and outcome [35]. Struc-
ture refers to the organization of care (eg presence of a
written policy about visiting patients in the ICU), whereas
process refers to the interaction between providers and
receivers of care (eg psychosocial support being offered
within the first 72 hours of admission to the ICU) [36].
Outcomes of care are at the level of the beneficiary of that
care (eg adequate treatment of pain) [36].
With good examples of systematic and scientifically
rigorous development trajectories for quality indicators
for palliative care lacking in the literature, we intend this
article to contribute to the establishment of a scientificallyrigorous standardized and applicable method of measur-
ing usable quality indicators. We do this by describing the
protocol of a study developing a quality indicators set for
palliative care for adults in Flanders (the Flemish speaking
part of Belgium), applicable in all settings providing pallia-
tive care, thus providing an example usable by other
countries interested in monitoring the quality of pal-
liative care.
Methods and design
In order to develop a comprehensive set of quality
indicators to monitor the quality of palliative care in
Flanders, four phases were followed in the development
process: 1) identification of existing quality indicators, 2)
development of a framework for quality of palliative
care, 3) indicator selection by expert consultations and
4) testing the draft quality indicator set in palliative
practice (Figure 1). The protocol of the present study
was approved by the Ethical Review Board of Brussels
University Hospital of the Vrije Universiteit Brussel.
Phase 1: identification of existing quality indicators
To get an overview of previous attempts to develop qual-
ity indicators for palliative care, a thorough systematic lit-
erature review was performed, building on a review done
in 2007 by Pasman et al [36]. With the field of quality
indicators and the literature on quality measurements in
palliative care developing quickly, it was important to up-
date the existing review using the same method and
search strategies but including the most recent literature
published between December 2007 and May 2009.
As in the original review, we searched four inter-
national databases (Pubmed, PsychINFO, EMBASE and
CINAHL). Two independent reviewers (KL and JC)
followed the same procedures as in the original review
by Pasman et al (results of this review update are
integrated into a paper published in Journal of Pain and
Symptom Management [37]).
Phase 2: identifying domains and themes of quality
palliative care
To achieve eventual comprehensiveness in the set of
quality indicators we conceived a conceptual framework
based on publications focussing on the determination of
high quality palliative care consisting of several domains
[38-40]: 1) physical, 2) psychological, social and existen-
tial, 3) information, communication, planning and deci-
sion making with patients, 4) with family and 5) with
other carers, 6) type of care, 7) coordination and con-
tinuity, 8) support of friend or family carers and 9)
structure of care (Table 2). Within these nine domains,
we distinguished several themes (see Table 3 for an ex-
ample of one domain with different themes).
Table 1 Definitions and examples of outcome measures, quality indicators and quality measurement instruments
Outcome measure/ variable Quality indicator Quality measurement instrument
Definition An essential component of quality
whereby the focus lies on patient’s or
relatives outcomes, measured at an
individual level.
Well defined and measurable aspect of
care, generally expressed in a number or
percentage, addressing a specific aspect of
care or a related outcome. Quality
indicators are usually expressed on
aggregated level.
Instruments that can be used to monitor
quality of care.
Characteristics Concerns outcomes of care Concerns structure, process or outcomes
of care
Concerns structure, process or outcomes
of care
In palliative care, outcome measures
provide a way to evaluate patient- and
family-level status and response to
treatment for symptoms and conditions in
physical, psychological and other domains
Clinically relevant, manageable and based
on existing evidence, or if not applicable
on consensus
These instruments are used to measure
outcome measures on individual level as
well as quality indicators on aggregated
level Individual and aggregated level
Contains standardized specifications
detailing the eligible population, data
collection procedures and types of
analyses needed to calculate the indicator
Individual level Aggregated level
Example Pain intensity Percentage of patients with moderate to
severe pain [10]
Numerated rating scales (NRS)
Quality of life Comfort Extent to which patients indicate that
caregivers respect their life stance [10]
McGill Quality of Life Questionnaire [44]
Patient’s appraisal of the quality of care
Relative’s appraisal of the quality of care
Extent to which direct relatives felt
supported by the caregivers immediately
after the patient’s death [10]
VOICES questionnaire [42,43]
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palliative care we held a consultation of experts representing
all relevant actors in palliative care, including patient and
family perspectives. The panel consisted of nurses and other
caregivers from all different specialized palliative care
services, physicians from different specialities, coordinators
of the Flemish Palliative Care networks, volunteers, spiritual
and religous counsellors, bereaved family members and
representatives of palliative patients i.e. large patient
organisations such as the Flemish Cancer League and the
Flemish Advisory Board for the Elderly.
The panel was asked to score each theme, as identified
through the literature, on a scale from 1 (least important)Indicators from literature  
put in selected themes
Phase 3: experts’ selection of 
indicators (by RAND method)
Phase 4: developing a draft quality ind
Phase 1: identification of 
existing quality indicators(by 
systematic review)
Figure 1 Flowchart of the 4 phases of the Flanders Study to developto 5 (most important). Additionally we asked them to se-
lect the three most important themes per domain
(questionnaires available upon request). Per domain
themes were ranked from most important to least import-
ant based on the mean scores and the frequency with
which the theme was indicated as most important within
the domain. Based on the mean scoring (highest tertile
across all domains) a number of themes were selected. To
be selected, there had to be consensus among the panel
members for each indicator, i.e. not more than four
members scoring outside the mean range [1-9]. With
every domain not then represented, we included one add-
itional theme most often indicated as one of the threePhase 2b: literature search and 
experts’ selection of themes
(within framework)
Phase 2a: developing a 
framework with important 
dimensions and themes
icator set and testing it in practice
Quality Indicators for Palliative Care.
Table 2 Selected domains for the quality of palliative
care in Flanders
Domain
1. Physical treatment and care
2. Psychological, social and existential treatment and care
3. Information, communication, planning and decision making with the
patient
4. Information, communication, planning and decision making with the
family
5. Information, communication, planning and decision making with
other caregivers
6. Type of care at the end of life
7. Coordination and continuity of care
8. Support of family and informal caregivers
9. Structure of care
Table 3 Example of themes within domains: Domain 1
‘Physical treatment and care’
Process of care
1. To measure or evaluate general symptom burden
2. To measure or evaluate pain
3. To measure or evaluate nausea and problems with digestion
4. To measure or evaluate fatigue and insomnia
5. To measure or evaluate decubitus
6. To measure or evaluate appetite
7. To measure or evaluate problems with respiration/tightness of the
chest
8. To measure or evaluate delirium
9. To measure or evaluate complaints on the mouth
10. To treat or care for physical symptoms once observed with the
patient
11. Mentioning in the patient’s file the presence of symptoms
12. Mentioning in the patient’s file the offered treatment and/or
medication for the purpose of physical problems
13. Mentioning in the patient’s file the result of the offered treatment
and/or medication for the purpose of physical problems
Outcome of care
1. Low general symptom burden
2. Absence of pain
3. Absence of problems with respiration/ tightness of the chest
4. Absence of delirium
5. Absence of decubitus
6. Absence of fatigue and insomnia
7. Absence of complaints of the mouth
8. Absence of nausea and problems with digestion
9. A good appetite
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underrepresented. We choose to preserve the nine
domains because the research team decided that all
domains should be covered in order to have a comprehen-
sive set. Additionally, experts were able to identify add-
itional themes that did not come out of the literature
review in a separate box for each domain and these were
added if consensus among the experts was reached (i.e.
more than one expert added this theme).
Phase 3: indicator selection by expert consultation
The selected themes were then translated into quality
indicators (i.e. with standardized specifications detailing
the eligible population, data collection procedures, nu-
merator and denominator), using the quality indicators
found in the systematic literature review in the first
phase. Then a second consecutive multidisciplinary pal-
liative care expert panel was organized for another selec-
tion round. This panel, like the first panel, consisted of
researchers in quality measurement or in palliative care,
nurses and other caregivers in the field of palliative care,
caregivers with a policy task in palliative care, bereaved
family members and patient representatives. The experts
could add quality indicators important to them not
presented in the list and could discard those they found
less important. For social and existential aspects of care,
no indicators were found in the literature so experts
were asked to suggest well-defined and measurable qual-
ity indicators for further development.
Unlike with the first expert consultation, we put to-
gether the second panel following the appropriateness
method of the Research ANd Development corporation
in collaboration with the University of California at Los
Angeles (RAND/UCLA) [41]. This is the only systematic
method for selecting quality indicators combining evi-
dence with consensus among stakeholders. We chose to
follow this method because, particularly for palliative
care, quality indicators have to be developed using other
evidence alongside expert opinion [29] as this area of
health care has a limited or methodologically weak evi-
dence base. Within this RAND/UCLA-method we
executed the five prescribed steps [42]:
1. Comprehensive literature review on the topic (i.e.
systematic literature review in phase 1) and
recommendation of a preliminary set of quality
indicators within the quality framework obtained
through the first expert panel.
2. Recruiting expert clinicians from professional
organisations reflecting the variety of specialities in
palliative care and inviting them to join a panel for a
two-stage process to rate the validity of the
indicators. These experts included a representative
from a patient organisation and a next-of-kin (eg
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in the first panel round.
3. Sending the draft indicators by post to the panel
members, who rated the indicators in terms of
appropriateness and relevance as measures of quality
on a scale from 1 (not appropriate or not necessary)
to 9 (very appropriate or very necessary)
(questionnaires available upon request).
4. Feeding back first-round scores to the panellists for a
second round of scoring in a face-to-face panel
meeting. Only indicators with a median score of 4, 5,
6 or higher but not reaching consensus were
discussed, modified where necessary and rescored.
The indicators with a median score of 7, 8 or 9 were
automatically added to the quality indicator set and
modified where necessary by the researchers.
5. Using the second-round scores to select only those
indicators rated highly for validity and on which
panel members had reached consensus. Indicators
rated low or not reaching consensus among
panellists were discarded.
After this second face-to-face consultation a draft set
of quality indicators was produced (Figure 1).
Phase 4: Developing and testing the draft quality
indicator set in palliative practice
The next challenge was to test the draft indicator set in
palliative care practice, in particular in order to assess its
usability and feasibility (eg work load). Up until now, the
draft set had been based on literature and expert opinion
and hence needed operationalization and validation in
practice, after which final adjustments could be made.
The indicators were transferred into questionnaires for
patients, medical staff and next-of-kin (eg partner, relative
or friend most closely involved) (Table 4). In order to obtain
all information needed to calculate the selected indicators
we composed our questionnaires using previously validated
questions from existing questionnaires when these existing
questions covered the quality indicator well. We for in-
stance used questions of the Views Of Informal Carers –
Evaluation of Services (VOICES) Questionnaire [43,44] and
the McGill Quality of Life Questionnaire [45], particularly
as these questionnaires are frequently used and alreadyTable 4 Distribution between observational units and study u
Patient Proxy Nex
Study unit before death before death afte
Care for the patient x x
Care for the next of kin
Process of care
Structure of carevalidated for a large group of respondents. For those
indicators where no validated questions were available
we composed questions ourselves. In a pre-test among
patients, family members and caregivers, we tested this not
yet validated questions and made an estimation of the time
needed to complete each questionnaire.When patients were
not able to complete the questionnaire themselves, a proxy
was assigned.
The questionnaires were divided over the observa-
tional units via four different palliative care services
(representing all the different palliative care services in
Flanders): the palliative home care team, the palliative care
unit, the palliative support team in the hospital and the
care home (only residents for whom a ‘palliative trajectory’
was initiated). A selection of services was recruited via the
existing palliative care networks in Flanders: a call was
sent out by the coordinators of these networks and
services could volunteer to participate. After recruitment,
a contact person for each service was appointed to
organize the mailing of the questionnaires together with a
researcher from the research team. The intention was to
capture a cross section of the quality of palliative care in
the different services at a particular moment, so one inter-
rogation only was conducted. This demanded that a ran-
dom selection was made of patients receiving palliative
care services as well of those who had received palliative
care services and had died between six weeks and six
months earlier; a representative snapshot of the quality of
existing care was thus created, taking into account coinci-
dental patient mix confounders. With the quality of care
susceptible to change over time, such a snapshot forms a
basic starting point. The choice of a single measurement
also makes the measurement of quality less burdensome
for staff.
Four different types of questionnaire (available upon
request), each measuring different quality indicators,
were sent:
– For adult patients currently receiving palliative care
– For next-of-kin involved in the care of a patient who
had died six weeks to six months previously
– For the central formal care provider (a nurse in the
palliative home care team and in the care home and
a nurse or a physician in the palliative support teamnits during the testing phase
Observational unit
t-of-kin Caregiver Care institution
r death before death after death before death
x
x
x x
x
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patient currently receiving palliative care
– For general practitioner of patients who had died in
the previous six weeks to six months
A maximum of 10 questionnaires was sent to any one
nurse or physician.
We were able to list which patients, care providers and
next-of-kin had already participated by the identifier
numbers on the returned questionnaires attributed to each
selected patient at the time of inclusion. In collaboration
with the coordinator of each service involved, reminders
were sent: one to patients and next-of-kin and up to two
to care providers. As the researchers have not disposed of
the list with patient, caregiver and family member contact
details, identifying individuals through the identifier
numbers on the questionnaires was not possible. After the
reminders were sent and the questionnaires returned the
collected data was analysed and quality indicators were
calculated for each participating service.
The testing phase was then evaluated in terms of feasibil-
ity and usability. First telephone interviews with non-
responding family members and family physicians were
held to assess reasons for non-participation. This was done
by a third independent party in order to preserve anonym-
ity of patients and family members from the researchers.
The contact person of the palliative service communicated
the phone numbers of family and physicians directly to this
independent person by email, based on the identifier
numbers received by the researchers. Furthermore
interviews were conducted with all coordinators and con-
tact persons to evaluate the usability of the indicators and
the procedure. Before the start of the interview all contact
persons were asked to question the other caregivers about
their experiences with the testing and the length of the
questionnaire(s) they completed.
Based on the results of the test in terms of usability
and feasibility, the indicator set, questionnaires and
manual were adapted in order to be ready for use by the
palliative services independently. We evaluated the in-
strument combining qualitative interviews with the
caregivers involved about the workload and future use of
the set and of quantitative psychometric analyses of the
dataset gathered (e.g. number of missing answers per in-
dicator). Furthermore, on request of the field, the indica-
tor set was divided into a required minimal data set with
complementary modules, each set usable separately or
combined by the palliative services interested in quality
measurement and improvement.
Discussion
This article presents a method followed in Flanders (the
Flemish speaking part of Belgium) for developing quality
indicators for palliative care. The method comprises fourphases: 1) a literature review identifying existing quality
indicators, 2) a literature review and expert consultation
to identify the important themes and domains for quality
palliative care, 3) quality indicator selection by expert
consultation following the internationally validated
RAND method and 4) testing the draft quality indicator
set in practice. This four-phase method combines the
different phases from previous development processes in
other countries (ie literature review, expert consultation,
practical test) and additionally includes patient and next-
of-kin perspectives, structure, process and outcome
indicators and applicability to all patients in all palliative
care services.
The method developed here can contribute to the de-
velopment of a standardized and functional set of quality
indicators for palliative care in other countries as it
meets the standards of scientific rigour and the level of
comprehensiveness required.
Choosing a multi phased method leading to
comprehensiveness
An important strength of the quality indicators develop-
ment method described here is that it contains several
phases to make the quality indicator set as comprehen-
sive as possible, i.e. measuring quality of care for all
adult palliative patients and across all domains relevant
to palliative care. By combining a literature review on
quality indicators with the building of a framework on
important themes in palliative care, all aspects of pallia-
tive care have been taken into account. Previous sets of
quality indicators for palliative care have tended to target
specific populations such as cancer patients or vulner-
able older people [9,16,18,46-48]. Our set, like that
developed in the Netherlands is characterized by applic-
ability to all setting and to all adult patient groups re-
ceiving palliative care [10] making it possible in the
future, after assessing case mix adjusters, to compare
scores of quality indicators not only over different
disciplines but over different care settings.
Choosing a combination of evidence through literature
review and expert consultation
As the thinking about quality indicators and the literature
about quality of palliative care is developing quickly, it is
necessary to review the field regularly, especially when be-
ginning to develop a new set of quality indicators. In the
literature we found researchers developing quality
indicators who had not performed such a review but had
started from an existing quality indicator set such as Saliba
et al. [22] who had selected indicators feasible for nursing
home quality assessment from the original ACOVE qual-
ity indicator set. This raises the question of whether com-
pletely new indicators need to be developed for a
particular country or whether existing indicators can be
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Either way, a literature review can help to reveal existing
indicators for further development and quality monitoring
in any country.
Consultation of experts in palliative care in order to
select the most important elements and indicators for
measuring quality is a key element in the methodology
described here and scoring by experts is important in
assessing the validity and usefulness of the proposed
indicators. Additionally it has the advantage that con-
sultation of relevant palliative care actors enhances the
acceptance and face-validity of the resulting indicator set
among the palliative care community [10]. The compos-
ition of the panel should reflect all relevant actors within
palliative care: those in medical practice and palliative
care, policymakers, researchers, patient representatives
and family. The latter two categories are often forgotten
in quality indicator development but are essential to the
creation of a comprehensive set of quality indicators
reflecting all perspectives in palliative practice. The ex-
pert consultation can best be done by the RAND/
UCLA-method [42].
Choosing inclusion of outcome, process and structure
indicators and involvement from all perspectives
Although measuring structure and process indicators
from medical charts or administrative databases may be
easier and cheaper, using only such sources for quality
measurements may cause problems. Such databases can
be limited, especially where indicators depend on precise
documentation of issues such as communication,
patient-reported outcomes or preferences [9]; such infor-
mation can only be obtained from patients and their
families themselves. On the other hand some researchers
and care providers tend to see quality only through the
perspective of the patient. This perspective does indeed
provide the best indication of whether good quality care
has been achieved [10], but data for calculating have to
be derived from individual care users which, apart from
the practical issues, also limits the possibility of measur-
ing all relevant aspects of the quality of palliative care
which might be susceptible to improvement. Therefore
many authors [9,29,35,38,39,49] suggest that a quality in-
dicator set, in order to be broad and comprehensive,
must include structure and process as well as outcome
indicators. We chose to translate our draft indicator set
into questionnaires for the different respondent groups,
patients, family and care providers, depending on which
we considered would be the most reliable raters for
selected quality indicators. Other quality researchers
have based their evaluation of usability and feasibility on
abstraction from patient records [11,14,23,25], thereby
automatically limiting the comprehensiveness of an indi-
cator set.Choosing a manageable testing of the quality indicator
set
A crucial stage in the development process is the testing
and evaluation of the set for usability and feasibility (eg
work load) in practice; before it can be taken up on a na-
tionwide scale the set needs operationalization and valid-
ation in palliative practice. Because of its extensive
character, we felt it necessary to perform this testing phase
in a small sample of palliative care service organisations.
To stimulate acceptance and use of quality indicators,
stakeholders from palliative practice should be involved
as early as possible in the development process. In Flan-
ders we also collaborated closely with the Flemish Feder-
ation for Palliative Care, which helped to promote the
project and enhance participation from care providers.
Work in progress
The quality indicator set for palliative care for adults in
Flanders is now fully developed and ready to be used in
practice to monitor quality of palliative care. Before
scores of quality indicators can be validly compared
across different services and care providers, however,
significant case mix adjusters and the discriminative
power of the indicators need to be assessed. Only if fu-
ture research in a larger sample confirms the discrimina-
tive power of the indicators can they be recommended
for comparative information or benchmarking [10] while
benchmarking itself can only be made possible by
implementing the quality indicator set on a large scale
in Flanders.
A standardized method for the development of quality
indicators for palliative care can also offer opportunities
on the international level; providing internationally com-
parable data [50].
Conclusion
There is an increasing recognition of the need for quality
indicators for palliative care in order to develop quality
programmes across countries and to provide evidence
to policymakers about the quality of the palliative care
they are providing. However, a standardized method of
developing quality indicators for palliative care has been
lacking. In this paper we propose a method which meets
the required level of scientific rigour and creates a sound
basis for achieving the comprehensiveness needed in
a set of quality indicators. The method suggested here
combines standard literature analyses with multidiscip-
linary expert consultations involving all relevant actors
within palliative care, following the RAND/UCLA-
method, the only validated systematic method for quality
indicator selection. Those wanting to develop indicators
in other countries can use this standardized method to
further develop and validate quality indicators for pallia-
tive care.
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